Cargando…

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology

Blood products in therapeutic transfusion are now commonly acknowledged to contain biologically active constituents during the processes of preparation. In the midst of a worldwide COVID-19 pandemic, preliminary evidence suggests that convalescent plasma may lessen the severity of COVID-19 if admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cognasse, Fabrice, Hamzeh-Cognasse, Hind, Duchez, Anne-Claire, Shurko, Natalia, Eyraud, Marie-Ange, Arthaud, Charles-Antoine, Prier, Amélie, Heestermans, Marco, Hequet, Olivier, Bonneaudeau, Brigitte, Rochette-Eribon, Sandrine, Teyssier, Françoise, Barlet-Excoffier, Valérie, Chavarin, Patricia, Legrand, Dominique, Richard, Pascale, Morel, Pascal, Mooney, Nuala, Tiberghien, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585295/ https://www.ncbi.nlm.nih.gov/pubmed/36275757 http://dx.doi.org/10.3389/fimmu.2022.1034379

Ejemplares similares

The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation
por: Ebermeyer, Theo, et al.
Publicado: (2023)

Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion
por: Duchez, Anne-Claire, et al.
Publicado: (2023)

LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand
por: Damien, Pauline, et al.
Publicado: (2015)

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
por: Heestermans, Marco, et al.
Publicado: (2022)

Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury
por: Tariket, Sofiane, et al.
Publicado: (2019)

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
por: Heestermans, Marco, et al.
Publicado: (2022)

Role of Siglec-7 in Apoptosis in Human Platelets
por: Nguyen, Kim Anh, et al.
Publicado: (2014)

A flow cytometry technique to study intracellular signals NF-κB and STAT3 in peripheral blood mononuclear cells
por: Lafarge, Sandrine, et al.
Publicado: (2007)

NF-κB Links TLR2 and PAR1 to Soluble Immunomodulator Factor Secretion in Human Platelets
por: Damien, Pauline, et al.
Publicado: (2017)

Streptococcus sanguinis-induced cytokine and matrix metalloproteinase-1 release from platelets
por: Cognasse, Fabrice, et al.
Publicado: (2014)

Direct contact of platelets and their released products exert different effects on human dendritic cell maturation
por: Hamzeh-Cognasse, Hind, et al.
Publicado: (2008)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

A Computerized Prediction Model of Hazardous Inflammatory Platelet Transfusion Outcomes
por: Nguyen, Kim Anh, et al.
Publicado: (2014)

Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage
por: Cancelas, Jose A., et al.
Publicado: (2022)

Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology?
por: Garraud, Olivier, et al.
Publicado: (2013)

Revisiting Platelets and Toll-Like Receptors (TLRs): At the Interface of Vascular Immunity and Thrombosis
por: Hally, Kathryn, et al.
Publicado: (2020)

Non-leukodepleted red blood cell transfusion in sepsis patients: beyond oxygenation, is there a risk of inflammation?
por: Garraud, Olivier, et al.
Publicado: (2014)

Platelets and Infections – Complex Interactions with Bacteria
por: Hamzeh-Cognasse, Hind, et al.
Publicado: (2015)

Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
por: Ebermeyer, Théo, et al.
Publicado: (2021)

The Non-Haemostatic Response of Platelets to Stress: An Actor of the Inflammatory Environment on Regenerative Medicine?
por: Cognasse, Fabrice, et al.
Publicado: (2021)

Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection
por: Hamzeh-Cognasse, Hind, et al.
Publicado: (2021)

Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains
por: Chabert, Adrien, et al.
Publicado: (2017)

Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units
por: Bubinski, Michal, et al.
Publicado: (2021)

Contribution of activated platelets to plasma IL-27 levels
por: Hamzeh-Cognasse, Hind, et al.
Publicado: (2013)

Human platelets and their capacity of binding viruses: meaning and challenges?
por: Chabert, Adrien, et al.
Publicado: (2015)

Preparation and Storage of Cryoprecipitate Derived from Amotosalen and UVA-Treated Apheresis Plasma and Assessment of In Vitro Quality Parameters
por: Kovacic Krizanic, Katarina, et al.
Publicado: (2022)

The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors
por: Cognasse, Fabrice, et al.
Publicado: (2015)

Platelet Inflammatory Response to Stress
por: Cognasse, Fabrice, et al.
Publicado: (2019)

Marqueurs inflammatoires chez les donneurs de plasmas convalescents
por: Cognasse, Fabrice
Publicado: (2021)

The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
por: Aoui, Chaker, et al.
Publicado: (2014)

The Non-Hemostatic Aspects of Transfused Platelets
por: Sut, Caroline, et al.
Publicado: (2018)

The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
por: Nebie, Ouada, et al.
Publicado: (2019)

Profils d’anticorps dans le plasma de convalescent COVID-19 traité pour traitement de réduction des agents pathogènes par Amotosalen/UVA
por: Corash, Laurence, et al.
Publicado: (2021)

P10-09. Altered release of RANTES from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides
por: Cognasse, F, et al.
Publicado: (2009)

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen–UVA photochemical treatment
por: Knutson, F, et al.
Publicado: (2015)

Key topographic parameters driving surface adhesion of Porphyromonas gingivalis
por: Papa, Steve, et al.
Publicado: (2023)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
por: Kroemer, Marie, et al.
Publicado: (2022)

MANUTENÇÃO DOS NÍVEIS DE ANTICORPOS NEUTRALIZANTES (NAB) E DE LIGAÇÃO PARA PROTEÍNAS DE NUCLEOCAPSÍDEOS (NP) DE SARS-CoV-2 EM UNIDADES DE PLASMA DE DOADORES CONVALESCENTES (CCP) TRATADOS POR AMOTOSALEN/UVA (A/UVA)
por: Wendel, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ois4ppho4atdk0i2tiquum1chr